GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Jun 2018 05:15 PM
RNS
Director/PDMR Shareholding
12 Jun 2018 02:00 PM
RNS
GSK announces changes to Corporate Executive Team
01 Jun 2018 01:00 PM
RNS
GSK completes Consumer Healthcare buyout
01 Jun 2018 09:42 AM
RNS
Total Voting Rights
29 May 2018 07:00 AM
RNS
GSK Once-daily single inhaler triple therapy COPD
21 May 2018 11:02 AM
RNS
ViiV granted EU marketing authorisation for Juluca
15 May 2018 01:39 PM
RNS
Director/PDMR Shareholding
11 May 2018 03:17 PM
RNS
Director/PDMR Shareholding
10 May 2018 05:20 PM
RNS
Block listing Interim Review
09 May 2018 05:05 PM
RNS
Director/PDMR Shareholding - replacement
09 May 2018 12:00 PM
RNS
Directorate Change
03 May 2018 06:31 PM
RNS
Result of General Meeting
03 May 2018 06:29 PM
RNS
Result of AGM
01 May 2018 02:45 PM
RNS
Total Voting Rights
27 Apr 2018 12:43 PM
RNS
Director/PDMR Shareholding
26 Apr 2018 03:30 PM
RNS
Director/PDMR Shareholding
25 Apr 2018 12:07 PM
RNS
Second Price Monitoring Extn
25 Apr 2018 12:02 PM
RNS
Price Monitoring Extension
25 Apr 2018 12:00 PM
RNS
1st Quarter Results
24 Apr 2018 05:41 PM
RNS
Trelegy Ellipta expanded US COPD indication
20 Apr 2018 03:15 PM
RNS
Director/PDMR Shareholding
20 Apr 2018 03:15 PM
RNS
Director/PDMR Shareholding
19 Apr 2018 07:00 AM
RNS
IMPACT study shows benefits of Trelegy Ellipta
18 Apr 2018 10:34 AM
RNS
Landmark IMPACT study to be published in NEJM
18 Apr 2018 10:02 AM
RNS
IMPACT study shows benefits of Trelegy Ellipta
17 Apr 2018 01:47 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:36 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:30 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:24 PM
RNS
Director/PDMR Shareholding
17 Apr 2018 01:20 PM
RNS
Director/PDMR Shareholding
13 Apr 2018 03:50 PM
RNS
Director/PDMR Shareholding
13 Apr 2018 03:44 PM
RNS
Director/PDMR Shareholding
13 Apr 2018 11:32 AM
RNS
Notice of GM
12 Apr 2018 03:04 PM
RNS
Director/PDMR Shareholding
03 Apr 2018 04:14 PM
RNS
Total Voting Rights
29 Mar 2018 01:00 PM
RNS
Notice of AGM
27 Mar 2018 07:00 AM
RNS
GSK agrees to acquire CH business from Novartis
23 Mar 2018 11:21 AM
RNS
ViiV - CHMP positive opinion for Juluca in Europe
23 Mar 2018 07:44 AM
RNS
Update regarding Pfizer Inc. Consumer Healthcare
23 Mar 2018 07:00 AM
RNS
Shingrix approved in Europe and Japan
19 Mar 2018 07:00 AM
RNS
GSK 2017 Form 20-F
13 Mar 2018 02:10 PM
RNS
Annual Financial Report
12 Mar 2018 04:30 PM
RNS
Director/PDMR Shareholding
08 Mar 2018 08:00 AM
RNS
GSK announces labelling update to Relvar Ellipta
05 Mar 2018 05:01 PM
RNS
ViiV Healthcare announces new dolutegravir data
05 Mar 2018 02:47 PM
RNS
Nucala OSMO study presented at AAAAI-WAO congress
05 Mar 2018 12:04 PM
RNS
Director/PDMR Shareholding
02 Mar 2018 01:11 PM
RNS
Director/PDMR Shareholding
01 Mar 2018 11:16 AM
RNS
Total Voting Rights
22 Feb 2018 04:54 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings